Hints and tips:
Related Topics
...But the vast majority of doctors Insys targeted were not oncologists....
...“The Insys example is the extreme . . ....
...Read the story at ft.com/insys....
...But prosecutors have already managed to hold accountable senior people at drugmaker Insys....
...Plus, the founder of the opioid maker Insys has been sentenced to five-and-a-half years in prison. The FT’s Hannah Kuchler explains what this means for other US pharmaceutical executives....
...(FT) Opioids Inc The pharmaceutical company Insys has come a long way from its former status as a Wall Street darling....
...Insys aims to complete the asset sales and address its liabilities within 90 days. Insys shares have fallen more than 97 per cent since their peak in 2015....
...Judge Kevin Gross, who is overseeing the Insys bankruptcy case, will have to decide whether those cases are just about pursuing money — as Insys argues — or about ensuring the company obeys the rules....
...(FT) Join our reporter Hannah Kuchler and documentary producer Tom Jennings on Reddit at 2pm EST today to discuss their investigation into Insys, whose executives were the first pharmaceutical bosses to...
...In total, eight Insys executives have been prosecuted....
...Insys said Mr Kapoor’s shares were being managed by an independent trust and would be until they are disposed. Mr Kapoor owns 63.2 per cent of Insys shares, worth about $194.6m....
...Insys, the maker of Subsys, a spray based on the very powerful opioid fentanyl, settled a case for $225m last month....
...If you or anyone you know has first-hand experience of the crisis, or contact with Insys, or patients who were prescribed their drug Subsys, please urge them to email me at hannah.kuchler@ft.com....
...In the US, John Kapoor, former chief executive of drugmaker Insys, will spend five and a half years in prison for a scheme to bribe doctors to prescribe the company’s opioid spray....
...(FT, The Conversation, World Economic Forum, Jama) US opioid crisis A joint investigation between the FT and US broadcaster PBS tells the inside story of how executives from Insys became the first pharma...
...Insys founder and chairman John Kapoor was the first high-ranking pharmaceutical executive to face serious criminal charges related to the addiction crisis....
...complex debt-derivatives product blamed for amplifying losses in the financial crisis, thousands of US screenwriters take on their private equity-backed agents, and the billionaire founder of drugmaker Insys...
...Subsys is also highly addictive, making Insys one of the leading actors in a US opioid epidemic estimated to kill more than 130 people a day....
...Oklahoma’s victory may embolden other states to pursue J&J, which has deeper pockets than opioid makers like Purdue Pharma, which has said it is considering filing for bankruptcy, and Insys, which has already...
...While Purdue Pharma is considering bankruptcy, and fellow opioid maker Insys has already filed for Chapter 11, J&J’s much deeper pockets make it an attractive target for legal action....
...The rest, including Johnson & Johnson, Teva and Insys could be at risk for another $13bn. These are big numbers....
...In June, Insys agreed to pay $225m to settle fraud charges and filed for Chapter 11 bankruptcy....
...Insys, the maker of the highly addictive opioid Subsys, has agreed to pay $225m to settle US criminal and civil cases against it....
...(FT) Taking the rap A conspiracy trial in the US was shown a rap video of salesmen from Insys Therapeutics exhorting greater sales of Subsys, an addictive painkiller....
...Insys Therapeutics has named current chief financial officer Andrew Long to lead the company, replacing its chief executive Saeed Motahari, as the company deals with ongoing legal costs related to its promotion...
International Edition